ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

US officials warn of severe mask and drug shortages

After China supply disruptions, India now slaps export controls on antibiotics

U.S. Vice President Mike Pence, the U.S. administration's point man on the coronavirus, departs from a briefing on the COVID-19 with U.S. Senate Democrats on Capitol Hill in Washington on March 3.   © Reuters

NEW YORK -- As the new coronavirus spreads in the U.S., health officials are warning of resource strains on several fronts, such as having just 10% of the N-95 masks needed by medical professionals in a full-blown outbreak, as well as potential drug shortages.

Following supply chain disruptions in China, India on Tuesday announced export controls on 26 active drug ingredients -- mostly antibiotics -- alarming the U.S. Food and Drug Administration. FDA chief Stephen Hahn told lawmakers at a Senate hearing that the agency is still going through the list to determine how much effect the controls will have on the country's medical supply chain.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more